drugset

drugset / Trial / NCT00259051

A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

NCT00259051 ↗

Phase 3 Completed 40 enrolled AstraZeneca Tanabe Pharma Corporation · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the pharmacodynamic effect of omeprazole n a Japanese non-erosive reflux disease population

Timeline

Start: 2004-01
Primary completion: 2004-08
Completion: 2004-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Omeprazole	Other / unclassified	—	—

Indications